Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chika Watanabe

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Surgery Today|June 26, 2017
Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-upYoshinari Ogawa, Katsumi Ikeda, Chika Watanabe, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional StudyKoji Takada, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
Surgical Neurology International|June 3, 2026
Posttraumatic intradiploic cyst-like lesion of the frontal bone without cortical disruption: A case reportChika Watanabe, Kiyoyuki Yanaka, Minami Saura, et al.
Anticancer Research|December 30, 2025
Efficacy and Safety of Subcutaneous Pertuzumab-Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from JapanHaruhito Kinoshita, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
BMC Cancer|November 29, 2025
Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs)Koji Takada, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
BMC Cancer|April 6, 2026
Clinical-genomic risk discordance and its impact on treatment selection in premenopausal women with node-positive hormone receptor-positive breast cancerMariko Nishikawa, Shinichiro Kashiwagi, Asuka Kochi, et al.
The Journal of Physical Chemistry. B|March 31, 2011
Salt has a biphasic effect on the higher-order structure of a DNA-protamine complexNaoko Makita, Yuko Yoshikawa, Yoshiko Takenaka, et al.
Indian Journal of Pediatrics|July 16, 2022
A Pediatric Case of Wheat-Dependent, Exercise-Induced Anaphylaxis Solely Associated with High-Molecular-Weight GluteninChika Watanabe, Yusuke Ando, Hideki Kumagai, et al.
Anticancer Research|January 30, 2026
Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma <i>In Situ</i>Koji Takada, Shinichiro Kashiwagi, Mayuko Hirata, et al.
Anticancer Research|December 30, 2025
Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalationWataru Goto, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Surgery Today|June 26, 2017
Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-upYoshinari Ogawa, Katsumi Ikeda, Chika Watanabe, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional StudyKoji Takada, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
Surgical Neurology International|June 3, 2026
Posttraumatic intradiploic cyst-like lesion of the frontal bone without cortical disruption: A case reportChika Watanabe, Kiyoyuki Yanaka, Minami Saura, et al.
Anticancer Research|December 30, 2025
Efficacy and Safety of Subcutaneous Pertuzumab-Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from JapanHaruhito Kinoshita, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
BMC Cancer|November 29, 2025
Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs)Koji Takada, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
BMC Cancer|April 6, 2026
Clinical-genomic risk discordance and its impact on treatment selection in premenopausal women with node-positive hormone receptor-positive breast cancerMariko Nishikawa, Shinichiro Kashiwagi, Asuka Kochi, et al.
The Journal of Physical Chemistry. B|March 31, 2011
Salt has a biphasic effect on the higher-order structure of a DNA-protamine complexNaoko Makita, Yuko Yoshikawa, Yoshiko Takenaka, et al.
Indian Journal of Pediatrics|July 16, 2022
A Pediatric Case of Wheat-Dependent, Exercise-Induced Anaphylaxis Solely Associated with High-Molecular-Weight GluteninChika Watanabe, Yusuke Ando, Hideki Kumagai, et al.
Anticancer Research|January 30, 2026
Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma <i>In Situ</i>Koji Takada, Shinichiro Kashiwagi, Mayuko Hirata, et al.
Anticancer Research|December 30, 2025
Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalationWataru Goto, Shinichiro Kashiwagi, Mariko Nishikawa, et al.
Pageof 4